Strategies of Coping with Pain: Differences Associated with the Histological Type of Lung Cancer

Author(s):  
Jacek Polański ◽  
Beata Jankowska-Polańska ◽  
Grzegorz Mazur ◽  
Mariusz Chabowski
2016 ◽  
Vol 36 (12) ◽  
pp. 6319-6326 ◽  
Author(s):  
TSUKIHISA YOSHIDA ◽  
TATSURO OKAMOTO ◽  
TOKUJIRO YANO ◽  
KAZUKI TAKADA ◽  
MIKIHIRO KOHNO ◽  
...  

2017 ◽  
Vol 141 (10) ◽  
pp. 1981-1986 ◽  
Author(s):  
Wentao Li ◽  
Shao-Hua Xie ◽  
Lap-Ah Tse ◽  
Jesper Lagergren

2015 ◽  
Vol 11 (2) ◽  
pp. 151-158 ◽  
Author(s):  
Li-Peng Liu ◽  
Xin-Xin Zhang ◽  
Long-Biao Cui ◽  
Jie Li ◽  
Juan-Li Yang ◽  
...  

2021 ◽  
pp. 203-208
Author(s):  
Nilgün Kanlıoğlu Kuman ◽  
Leyla Didem Kozacı ◽  
Serdar Şen ◽  
Ekrem Şentürk ◽  
Salih Çokpınar ◽  
...  

Objectives: The number of human studies on the association and clinical signicance of alterations in IL-6, sP-Selectin, TNF-α, BNP-32, or procalcitonin (PCT) in lung cancer is small. We aimed to investigate the alterations of proinammatory cytokines and acute-phase reactants in blood and pleural uid and determine their clinical diagnostic or prognostic signicances regarding tumor type, stage, size, standardized uptake value (SUV), and lymphovascular invasion (LVI). Methods: Levels of IL-6, TNF-α, BNP-32, PCT, and sP-selectin were evaluated in blood samples st th st th th obtained preoperatively and postoperatively on 1 , 6 hours and 1 , 4 , and seven days. They also were evaluated in pleural st uid samples obtained postoperatively on 1 hour, and rst and fourth days. These results were analyzed according to the cell type, size, stage, SUV, and LVI of lung cancer. IL-6 values in plasma and pleural uid had Results: various signicant relationships and correlations with histological type, diameter, SUV, stage, and LVI of the tumor. TNF-α values in plasma or pleural uid had signicant relationships with LVI only. PCT values in plasma or pleural uid had signicant relationships with the tumor's diameter, SUV, and LVI. BNP-32 values in plasma or pleural uid had signicant relationships with histological type and SUV of the tumor. sP-Selectin values in plasma or pleural uid had signicant relationships with the stage and SUV of the tumor. We determined various signicant associations and correlations of proinammatory cytokines wi Conclusions: th histological type, size, stage, LVI, and SUV of lung cancer. Studies on this subject would serve to develop diagnostic and prognostic methods in lung cancers.


2015 ◽  
Vol 9 ◽  
pp. CMO.S32707 ◽  
Author(s):  
Akira Tadokoro ◽  
Nobuhiro Kanaji ◽  
Tomoya Ishii ◽  
Naoki Watanabe ◽  
Takuya Inoue ◽  
...  

We report a case of squamous cell lung cancer with transbronchial dissemination in a 73-year-old man. Bronchoscopic examination revealed multiple bronchial mucosal nodules that existed independently of one another. We reviewed 16 previous cases of endobronchial metastasis in lung cancer. All patients were men. Among the reports that described the smoking history, most patients were smokers (6/7), and the most frequent histological type of cancer was squamous cell carcinoma (11/17). Although hematogenous and lymphogenous routes have been reported as metastatic mechanisms, no previous cases involving transbronchial dissemination have been described. Transbronchial dissemination may be an alternative pathway of endobronchial metastasis.


2019 ◽  
Vol 31 (2) ◽  
pp. 306-315 ◽  
Author(s):  
Lei Yang ◽  
◽  
Ning Wang ◽  
Yannan Yuan ◽  
Shuo Liu ◽  
...  

2021 ◽  
Author(s):  
Guihong Zhang ◽  
Yue Jiao Liu ◽  
Ming De Ji

Abstract Purpose: A comprehensive population-based study on risk and prognostic factors of lung cancer with brain metastasis is lacking. Methods: 95191 patients diagnosed with lung cancer between 2010 and 2017 were collected from the Surveillance, Epidemiology and End Results (SEER) database. Patients were stratified by different variables. Multivariable logistic and Cox regression were applied to analyze the risk and prognostic factors of brain metastasis among lung cancer patients, respectively. The Fine and Gray’s competing risk regression model was performed to obtain prognostic factors associated with cancer-specific mortality.Results: Among the 95191 patients diagnosed with lung cancer, 10765 patients have brain metastasis, with a metastatic incidence of 11.31%. The primary site of tumor, residence type, age, histological type, race and extracranial metastasis were all independent risk factors of brain metastasis. Compared with other histological types, small cell lung cancer displayed a highest incidence of brain metastasis (16.62%). The median overall survival (OS) among lung cancer patients with brain metastasis was only 6.05 months. The primary site of tumor, median household income, age, histological type, race, gender and extracranial metastasis were all associated with the prognosis of brain metastasis. Patients with squamous cell carcinoma had the worst prognosis, the median OS was only 3.68 months. And our established new nomogram showed a good discriminative ability on predicting the probability of cancer-specific survival among patients with brain metastasis, the C-index was 0.61.Conclusion: Our study provided a deeper insight into the risk factors and prognosis of brain metastasis among lung cancer patients.


1980 ◽  
Vol 66 (2) ◽  
pp. 223-233
Author(s):  
Claudio Modini ◽  
Clemente Iascone ◽  
Franco Cicconetti ◽  
Massimo Zerilli ◽  
Sergio Stipa

A statistical comparison between survival and type of resection: Lobectomy and pneumonectomy was made out of 108 patients who had undergone curative resection for lung cancer (with a minimum 3 years follow-up). Analysis was first made on the whole series, then the patients were classified according to histological type (W-PL) or staging (TNM) and finally stratified in 2 control levels (stage and histological type). There was a better prognosis for lobectomy than for pneumonectomy, referring to a single subgroup, but not in a statistically significant way. There was a better prognosis for patients who had been operated for lobectomy S (2) 2 LOB with a 36 months survival for 85 %. There were better results for squamous cell carcinoma stage I and II S(2) 1 PNE, for those patients who had been operated for pneumonectomy with a median survival of 32 months and over 3 years survival for 41.7 %.


Sign in / Sign up

Export Citation Format

Share Document